Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled Interventional Trial to Investigate the Efficacy of Amiloride for the Treatment of Edema in Human Nephrotic Syndrome

NCT05079789 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05079789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05079789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled Interventional Trial to Investigate the Efficacy of Amiloride for the Treatment of Edema in Human Nephrotic Syndrome
Lead sponsor
University Hospital Tuebingen
Phase
Phase 3
Overall status
Terminated
Start date
June 8, 2020
Completion date
November 20, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

edema, nephrotic syndrome, sodium retention